LearnGlossaryMarketStocksSuperinvestorsSign in

IMCR

Immunocore Holdings plc

Healthcare · $1.6B market cap

Verdict

We can't put a fair value on IMCR right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth2.8% a year✗
Sales growth57.4% a year✓
Free cash flow growth6.3% a year✗
Return on invested capital-7.6%✗

Follow IMCR

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds IMCR. In Q1 2026, 1 opened a position. Who we track

Howard Marks

Oaktree Capital Management · as of Q2 2026

$766.4M

833,000 shares

Moves in Q1 2026

New position: Howard Marks

About Immunocore Holdings plc

Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works